Profil
Ronald Filippo is currently Chief Information Officer & Executive VP at Madrigal Pharmaceuticals, Inc. since 2023.
Formerly, Mr. Filippo was Senior Vice President-Digital at Moderna, Inc. from 2021 to 2023 and held the position of Head-Data & AI Transformation at Teva Pharmaceuticals, Inc. Education includes undergraduate studies at Thomas Jefferson University.
Postes actifs de Ronald Filippo
| Sociétés | Poste | Début |
|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 21/11/2023 |
Anciens postes connus de Ronald Filippo
| Sociétés | Poste | Fin |
|---|---|---|
| MODERNA, INC. | Corporate Officer/Principal | 01/11/2023 |
Teva Pharmaceuticals, Inc.
Teva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | 01/09/2021 |
Formation de Ronald Filippo
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Thomas Jefferson University
Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs for cardiovascular, metabolic and liver diseases | Health Technology |
Moderna, Inc.
Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Teva Pharmaceuticals, Inc.
Teva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
















